首页
学习
活动
专区
工具
TVP
发布
精选内容/技术社群/优惠产品,尽在小程序
立即前往

AI如何赋能药物研发?FDA详述机遇和挑战|全球监管动态

▎药明康德内容团队编辑

参考资料:

[1]  Artificial Intelligence and Machine Learning (AI/ML) for Drug Development. Retrieved May 11, 2023, from https://www.fda.gov/science-research/science-and-research-special-topics/artificial-intelligence-and-machine-learning-aiml-drug-development

[2] AI and machine learning: FDA spells out specifics from drug discovery to manufacturing. Retrieved May 11, 2023, from https://endpts.com/ai-and-machine-learning-fda-spells-out-specifics-from-discovery-to-manufacturing/

[3] FDA Releases Two Discussion Papers to Spur Conversation about Artificial Intelligence and Machine Learning in Drug Development and Manufacturing. Retrieved May 11, 2023, from https://www.fda.gov/news-events/fda-voices/fda-releases-two-discussion-papers-spur-conversation-about-artificial-intelligence-and-machine

  • 发表于:
  • 原文链接https://kuaibao.qq.com/s/20230515A00W6V00?refer=cp_1026
  • 腾讯「腾讯云开发者社区」是腾讯内容开放平台帐号(企鹅号)传播渠道之一,根据《腾讯内容开放平台服务协议》转载发布内容。
  • 如有侵权,请联系 cloudcommunity@tencent.com 删除。

相关快讯

扫码

添加站长 进交流群

领取专属 10元无门槛券

私享最新 技术干货

扫码加入开发者社群
领券